Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1975 1
1977 2
1980 2
1981 1
1982 1
1983 1
1984 3
1985 3
1986 1
1987 2
1989 3
1990 1
1991 4
1992 5
1993 2
1994 3
1995 7
1996 4
1997 9
1998 6
1999 13
2000 7
2001 6
2002 10
2003 9
2004 9
2005 7
2006 18
2007 20
2008 14
2009 26
2010 27
2011 21
2012 20
2013 27
2014 32
2015 39
2016 36
2017 36
2018 37
2019 36
2020 247
2021 407
2022 253
2023 176
2024 73

Text availability

Article attribute

Article type

Publication date

Search Results

1,417 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hypogonadotropic hypogonadism 19 with or without anosmia"
Page 1
Neurological Sequelae of COVID-19.
Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ. Ahmad SJ, et al. J Integr Neurosci. 2022 Apr 6;21(3):77. doi: 10.31083/j.jin2103077. J Integr Neurosci. 2022. PMID: 35633158 Free article. Review.
The various neurological disorders associated with COVID-19 range in severity from mild symptoms such as headache, or myalgias to more severe symptoms such as stroke, psychosis, and anosmia. While some of the COVID-19 associated neurological complications are mild and reve …
The various neurological disorders associated with COVID-19 range in severity from mild symptoms such as headache, or myalgias to more sever …
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, Galasko D, Kieburtz K, Merchant K, Mollenhauer B, Poston KL, Seibyl J, Simuni T, Tanner CM, Weintraub D, Videnovic A, Choi SH, Kurth R, Caspell-Garcia C, Coffey CS, Frasier M, Oliveira LMA, Hutten SJ, Sherer T, Marek K, Soto C; Parkinson's Progression Markers Initiative. Siderowf A, et al. Lancet Neurol. 2023 May;22(5):407-417. doi: 10.1016/S1474-4422(23)00109-6. Lancet Neurol. 2023. PMID: 37059509 Free PMC article.
Anosmia-A Clinical Review.
Boesveldt S, Postma EM, Boak D, Welge-Luessen A, Schöpf V, Mainland JD, Martens J, Ngai J, Duffy VB. Boesveldt S, et al. Chem Senses. 2017 Sep 1;42(7):513-523. doi: 10.1093/chemse/bjx025. Chem Senses. 2017. PMID: 28531300 Free PMC article. Review.
Anosmia and hyposmia, the inability or decreased ability to smell, is estimated to afflict 3-20% of the population. ...As limited evidence-based treatments exist for anosmia, dissemination of information on anosmia-related health risks is needed. ...
Anosmia and hyposmia, the inability or decreased ability to smell, is estimated to afflict 3-20% of the population. ...As limited evi …
Widening the Spectrum of Risk Factors, Comorbidities, and Prodromal Features of Parkinson Disease.
Schrag A, Bohlken J, Dammertz L, Teipel S, Hermann W, Akmatov MK, Bätzing J, Holstiege J. Schrag A, et al. JAMA Neurol. 2023 Feb 1;80(2):161-171. doi: 10.1001/jamaneurol.2022.3902. JAMA Neurol. 2023. PMID: 36342675 Free PMC article.
Consistent with previous reports, risk factors and prodromal features associated with PD included traumatic brain injury, odds ratio (OR), 1.62; 95% CI, 1.36-1.92; alcohol misuse, OR, 1.32; 95% CI, 1.21-1.44; hypertension, OR, 1.29; 95% CI, 1.26-1.31; anosmia, OR, 2.16; 95 …
Consistent with previous reports, risk factors and prodromal features associated with PD included traumatic brain injury, odds ratio (OR), 1 …
Olfactory Cleft Measurements and COVID-19-Related Anosmia.
Altundag A, Yıldırım D, Tekcan Sanli DE, Cayonu M, Kandemirli SG, Sanli AN, Arici Duz O, Saatci O. Altundag A, et al. Otolaryngol Head Neck Surg. 2021 Jun;164(6):1337-1344. doi: 10.1177/0194599820965920. Epub 2020 Oct 13. Otolaryngol Head Neck Surg. 2021. PMID: 33045908 Free PMC article.
OBJECTIVE: This study aimed to investigate the differences in olfactory cleft (OC) morphology in coronavirus disease 2019 (COVID-19) anosmia compared to control subjects and postviral anosmia related to infection other than severe acute respiratory syndrome coronavi …
OBJECTIVE: This study aimed to investigate the differences in olfactory cleft (OC) morphology in coronavirus disease 2019 (COVID-19) anos …
Signs and symptoms of COVID-19 in patients with multiple sclerosis.
Schiavetti I, Carmisciano L, Ponzano M, Cordioli C, Cocco E, Marfia GA, Inglese M, Filippi M, Radaelli M, Bergamaschi R, Immovilli P, Capobianco M, De Rossi N, Brichetto G, Scandellari C, Cavalla P, Pesci I, Confalonieri P, Perini P, Trojano M, Lanzillo R, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M, Sormani MP; MuSC-19 Study Group. Schiavetti I, et al. Eur J Neurol. 2022 Dec;29(12):3728-3736. doi: 10.1111/ene.15554. Epub 2022 Sep 23. Eur J Neurol. 2022. PMID: 36086905 Free PMC article.
RESULTS: From March 2020 to November 2021, data were collected from 1354 MS patients with confirmed infection of COVID-19. Ageusia and anosmia was less frequent in older people (odds ratio [OR] 0.98; p = 0.005) and more in smoker patients (OR 1.39; p = 0.049). ...Differenc …
RESULTS: From March 2020 to November 2021, data were collected from 1354 MS patients with confirmed infection of COVID-19. Ageusia and an …
COVID-19 Anosmia Reporting Tool: Initial Findings.
Kaye R, Chang CWD, Kazahaya K, Brereton J, Denneny JC 3rd. Kaye R, et al. Otolaryngol Head Neck Surg. 2020 Jul;163(1):132-134. doi: 10.1177/0194599820922992. Epub 2020 Apr 28. Otolaryngol Head Neck Surg. 2020. PMID: 32340555 Review.
There is accumulating anecdotal evidence that anosmia and dysgeusia are associated with the COVID-19 pandemic. To investigate their relationship to SARS-CoV2 infection, the American Academy of Otolaryngology-Head and Neck Surgery developed the COVID-19 Anosmia Repor …
There is accumulating anecdotal evidence that anosmia and dysgeusia are associated with the COVID-19 pandemic. To investigate their r …
COVID-19 with and without anosmia or dysgeusia: A case-control study.
Dev N, Sankar J, Gupta N, Meena RC, Singh C, Gupta DK, Sen MK. Dev N, et al. J Med Virol. 2021 Apr;93(4):2499-2504. doi: 10.1002/jmv.26784. Epub 2021 Jan 22. J Med Virol. 2021. PMID: 33417259
All adult COVID-19 patients with new onset anosmia or dysgeusia at admission were included in study group. Equal number of age and gender matched COVID-19 patients without anosmia or dysgeusia at admission were included in the control group. ...Anosmia (96%, …
All adult COVID-19 patients with new onset anosmia or dysgeusia at admission were included in study group. Equal number of age and ge …
Multiple Neuroinvasive Pathways in COVID-19.
Bougakov D, Podell K, Goldberg E. Bougakov D, et al. Mol Neurobiol. 2021 Feb;58(2):564-575. doi: 10.1007/s12035-020-02152-5. Epub 2020 Sep 29. Mol Neurobiol. 2021. PMID: 32990925 Free PMC article. Review.
Multiple neurological symptoms of COVID-19 have been described. These involve anosmia/ageusia, headaches, seizures, mental confusion and delirium, and coma. ...
Multiple neurological symptoms of COVID-19 have been described. These involve anosmia/ageusia, headaches, seizures, mental confusion …
1,417 results